Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Cardiovascular

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • Successful Launch of Cardiovascular Risk Assessment Program

    November 18, 2009
    Read how Innovex is working with the UK National Health Service to assess large numbers of people at risk for cardiovascular disease.

  • Takeda Hits the Ground Running in New European Territory, with Help from Innovex

    September 25, 2009
    Our customer was faced with the challenge to launch a countrywide sales team in Spain within 12 weeks.

  • Cardiovascular management in the UK

    September 23, 2009
    This case study reviews how a Primary Care Trust used a combination of social marketing and Nurse Advisors to bring cardiovascular care to local communities.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

  • Multiple Phase I Study for Two Compounds

    June 30, 2009
    Learn how Quintiles efficiently managed 15 Phase I studies.

  • QUINTILES ANNOUNCES NEW GHANA OFFICE


    June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana.

  • QT Population Modeling and Simulation Case Study

    June 15, 2009
    The importance of determining the most strategic Phase I/IIa study conducted by leading specialists shouldn’t be understated. Gain insight into QT and Population Modeling & Simulation.

  • Heart Failure

    March 27, 2009
    A double-blind, randomized, placebocontrolled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction

  • Cardiovascular Expertise Results in Faster Enrollment Speed

    March 27, 2009
    Mega-trials require mega-expertise, especially when the global study is for an innovative cardiovascular drug to treat patients with acute coronary syndrome who have also undergone coronary artery bypass surgery.

  • Chronic Heart Failure

    March 27, 2009
    A phase II, double-blind, randomized, placebocontrolled, dose-comparative study of the efficacy, tolerability and safety of Drug X in subjects with chronic heart failure NYHA Class II/III